“Our findings could lead to a better understanding of how ALS develops in people who have this mutation,” said principal investigator Stephen Kolb, MD, PhD, professor of neurology and biological chemistry and pharmacology at Ohio State.
May 24, 2023
Ohio State scientist is studying a novel gene therapy model that could lead to treatment for widespread neurological diseases.
October 17, 2022
News
The Institute will coordinate existing strengths to accelerate the expansion of therapies.
April 22, 2022
